Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6577 - 6584 of 12085 results

US Visa Processing in Turkey Resumes on a Limited Basis; Again, Turkey Responds in Kind
November 14, 2017| Blog| Viewpoint

Travel Ban: 9th Circuit Allows Partial Implementation
November 14, 2017| Blog| Viewpoint

USPTO Publishes New Rule Governing Privilege for Patent Attorneys and Agents
November 14, 2017| Blog| Viewpoint

Labs Wage Legal Fights Over Fees, Medical Necessity Checks
November 14, 2017| News

ACA & Access to Birth Control (Audio)
November 14, 2017| News

How Eliminating The Medical Expense Deduction Could Increase Medicaid Spending
November 14, 2017| News

Whether Title VII Forbids Sexual Orientation Discrimination is Now Ripe for SCOTUS Review
November 14, 2017| News

Want to Save Trees AND Comply with ERISA? Here’s How!
November 13, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
